Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system

Infection and Immunity

Volumn 69, Issue 9, 2001, Pages 5709-5715

  Lee, J S ^a   Pushko, P ^a   Parker, M D ^a   Dertzbaugh, M T ^a   Smith, L A ^a   Smith, J F ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CIS ACTING ELEMENT; HELPER FACTOR; PROTEIN HC VRP; RNA; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VACCINE; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; IMMUNOGENICITY; LD 50; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPLICON; SERODIAGNOSIS; STRUCTURAL GENE; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS PARTICLE; WESTERN BLOTTING;

ANIMALS; BACTERIAL VACCINES; BOTULINUM TOXIN TYPE A; BOTULISM; CELL LINE; CLOSTRIDIUM BOTULINUM; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; GENETIC VECTORS; MICE; MICE, INBRED BALB C; REPLICON; VACCINATION; VACCINES, SYNTHETIC;

EID: 0034876256     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.9.5709-5715.2001     Document Type: Article

References (25)

1. The complete sequence of botulinum neurotoxin type A and comparison with other clostridial neurotoxins
2. Purification, potency, and efficacy of the botulinum neurotoxin type A binding domain from Pichia pastoris as a recombinant vaccine candidate
3. Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A
4. Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli
5. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge
6. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
7. Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome
8. Botulism
9. The in vitro displacement of adsorbed model antigens from aluminum-containing adjuvants by interstitial proteins
10. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates
11. Vaccination with two different vaccinia recombinant viruses: Long-term inhibition of secondary vaccination
12. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon
13. Expression of tetanus toxin fragment C in E. coli: High-level expression by removing rare codons
14. Replicon-helper systems from attenuated Venezuelan equine encephalitis viras: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
15. Genesis of Sindbis virus by in vivo recombination of nonreplicative RNA precursors
16. Expression of tetanus toxin fragment C in yeast: Gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA
17. DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice
18. Development of recombinant vaccines for botulinum neurotoxin
19. Structure and replication of the alphavirus genome
20. The alphaviruses: Gene expression, replication, and evolution
21. Clostridial botulinum neurotoxin
22. Botulism
23. The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by the nucleotide sequence analysis of the encoding gene
24. Recombination between Sindbis virus RNAs